These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-acting interferon-alpha 2a modified with a trimer-structured polyethylene glycol: preparation, in vitro bioactivity, in vivo stability and pharmacokinetics. Jo YW; Youn YS; Lee SH; Kim BM; Kang SH; Yoo M; Choi EC; Lee KC Int J Pharm; 2006 Feb; 309(1-2):87-93. PubMed ID: 16406701 [TBL] [Abstract][Full Text] [Related]
5. Development and pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a (40 kD). Reddy KR Semin Liver Dis; 2004; 24 Suppl 2():33-8. PubMed ID: 15346244 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, tissue distribution, excretion, and antiviral activity of pegylated recombinant human consensus interferon-α variant in monkeys, rats and guinea pigs. Cai Y; Zhang Z; Fan K; Zhang J; Shen W; Li M; Si D; Luo H; Zeng Y; Fu P; Liu C Regul Pept; 2012 Jan; 173(1-3):74-81. PubMed ID: 21985916 [TBL] [Abstract][Full Text] [Related]
7. A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation. Rosendahl MS; Doherty DH; Smith DJ; Carlson SJ; Chlipala EA; Cox GN Bioconjug Chem; 2005; 16(1):200-7. PubMed ID: 15656592 [TBL] [Abstract][Full Text] [Related]
8. Regulation of gene expression by pegylated IFN-alpha2b and IFN-alpha2b in human peripheral blood mononuclear cells. Brassard DL; Delorenzo MM; Cox S; Leaman DW; Sun Y; Ding W; Gavor S; Spond J; Goodsaid F; Bordens R; Grace MJ J Interferon Cytokine Res; 2004 Aug; 24(8):455-69. PubMed ID: 15320959 [TBL] [Abstract][Full Text] [Related]
9. Biologic activity of polyethylene glycol12000-interferon-alpha2b compared with interferon-alpha2b: gene modulatory and antigrowth effects in tumor cells. Vyas K; Brassard DL; DeLorenzo MM; Sun Y; Grace MJ; Borden EC; Leaman DW J Immunother; 2003; 26(3):202-11. PubMed ID: 12806274 [TBL] [Abstract][Full Text] [Related]
15. Pegylated protein encapsulated multivesicular liposomes: a novel approach for sustained release of interferon alpha. Vyas SP; Rawat M; Rawat A; Mahor S; Gupta PN Drug Dev Ind Pharm; 2006 Jul; 32(6):699-707. PubMed ID: 16885125 [TBL] [Abstract][Full Text] [Related]
16. A new method to produce monoPEGylated dimeric cytokines shown with human interferon-α2b. Chang CH; Rossi EA; Cardillo TM; Nordstrom DL; McBride WJ; Goldenberg DM Bioconjug Chem; 2009 Oct; 20(10):1899-907. PubMed ID: 19736932 [TBL] [Abstract][Full Text] [Related]
17. Pegylated interferon-alpha2a kinetics during experimental haemodialysis: impact of permeability and pore size of dialysers. Barril G; Quiroga JA; Sanz P; Rodrìguez-Salvanés F; Selgas R; Carreño V Aliment Pharmacol Ther; 2004 Jul; 20(1):37-44. PubMed ID: 15225169 [TBL] [Abstract][Full Text] [Related]
18. Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation. François C; Bernard I; Castelain S; Charleston B; Fray MD; Capiod JC; Duverlie G Antimicrob Agents Chemother; 2005 Sep; 49(9):3770-5. PubMed ID: 16127052 [TBL] [Abstract][Full Text] [Related]
19. Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B. ter Borg MJ; Hansen BE; Herrmann E; Zeuzem S; Cakaloglu Y; Karayalcin S; Flisiak R; van' t Veen A; de Man RA; Schalm SW; Janssen HL; Haagmans BL; Antivir Ther; 2007; 12(8):1285-94. PubMed ID: 18240868 [TBL] [Abstract][Full Text] [Related]
20. Pegylation and Cell Based Bioassay of Human Interferon-α2b Along its Docking Studies and Effect on Plasma Half-Life. Shahzadi SK; Qadir MA; Mahmood N; Ahmed M Protein Pept Lett; 2020; 27(3):219-224. PubMed ID: 31612813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]